Fig. 1From: Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonanceRepresentative cases of a healthy subject (A) and of left ventricular (LV) hypertrophy (LVH) in an athlete (B) and in patients with hypertensive heart disease (HHD) (C), hypertrophic cardiomyopathy (HCM) (D) and cardiac amyloidosis (E), respectivelyBack to article page